- 期刊
Prostaglandin E1 Versus Papaverine for Diagnosis of Erectile Dysfunction
前列腺素E1和罌粟鹼在診斷陽萎的比較
摘要
對50位勃起功能失常的病人，我們做同一位病人陰莖海綿體內，前列腺素E1和甖粟鹼的注射來比較診斷陽萎的功效。我們以不同劑量做隔週注射，觀察病人陰莖勃起的反應，並記錄注射後的所有副作用。結果顯示，20mcg前列腺素E1所引起的勃起要比60mg罌粟鹼的反應要好；而前列腺素E1的反應和劑量成正比，注射後立即引起的副作用，在二者之間並沒什麼差異，98%病人都能忍受少許的注射疼痛，至於注射後引發的過長時間勃起這種不方便，甖粟鹼則有較高(8%)的危險；基於這種考慮，臨床上前前列腺素E1應該是較安全的診斷用藥。
關鍵字
無資料並列摘要
In 50patients with erectile dysfunction, a comparative study with intracarvernous injection of prostaglandin E1 (PGE1) and papaverine was perfourmed. Erections with prostaglandin E1 (20 mcg) were equal or superior to those with papaverine (60 mg) in each cases. Dose-dependent effect of PGE1 was also remarkable. There was no difference of the immediate side effect between the two agents. Most of the injection pain was tolerable. Concerning the late side effect as prolong erection, PGE1 injection had less incidence than that of papaverine. Our study suggested that PGE1 was a potentially better alterantive for the diagnosis of erectile dysfunction. (J Urol R.O.C., 1: 92-96, 1990)
延伸閱讀
- Wang, C. J., Wu, C. C., Huang, C. H., & Chiang, C. P. (1992). 海綿體注射前列腺素E1或罌粟鹼對於陽萎之評估的比較研究. The Kaohsiung Journal of Medical Sciences, 8(11), 585-590. https://doi.org/10.6452/KJMS.199211.0585
- Dong, T. T. N. (2023). Part I. 模擬移動床色譜法在人參皂苷、羥氯喹和蝦紅素分離中的應用Part II. 靈芝和冬蟲夏草萃取物作為益生源提高益生菌維萊森斯芽孢桿菌抗菌活性試驗 [doctoral dissertation, I-SHOU University]. Airiti Library. https://www.airitilibrary.com/Article/Detail?DocID=U0074-0301202316352000
- Yang, Y. F. (2011). Quinazoline類α1-腎上腺素受體拮抗劑在培養心肌細胞毒性作用機制之探討 [doctoral dissertation, National Taiwan University]. Airiti Library. https://doi.org/10.6342/NTU.2011.01452
- 張裕純（2003）。白葉釣樟與薊罌粟化學成分及生物活性之研究〔博士論文，高雄醫學大學〕。華藝線上圖書館。https://www.airitilibrary.com/Article/Detail?DocID=U0011-0707200816001911
- 張櫻霖、黃一勝、楊啟瑞、張吉隆、張兆祥、吳錫金（1991）。使用前列腺素E1行陰莖海綿體注射做為陽萎病人之門診治療。中華民國泌尿科醫學會雜誌，2(2)，465-471。https://doi.org/10.7024/JUAROC.199106.0465